Base de donnée de Produits de santé homologués
| DESIGNATION | DCI | TITULAIRE AMM | PAYS D'ORIGINE | PGHT(FCFA) | N°AMM | DATE EXPIRATION AMM |
|---|---|---|---|---|---|---|
| BEKRAZOL 200mg/5mL Suspension buvable Fl/10 mL | ALBENDAZOLE | BEKRA PHARMA | Inde | 478.85 | AMM_2018_4346 | 2023-10-11 |
| BEKRAZOL 400mg Comprimé B/1 | ALBENDAZOLE | BEKRA PHARMA | Inde | 478.85 | AMM_2018_4360 | 2023-10-11 |
| AKEROL 5mg Comprimé orosoluble B/20 | DESLORATADINE | BEKRA PHARMA | Inde | 2131.86 | AMM_2018_4315 | 2023-10-09 |
| AKEROL SIROP 2,5mg/5mL Sirop Fl/60 mL | DESLORATADINE | BEKRA PHARMA | Inde | 1639.89 | AMM_2018_4330 | 2023-10-09 |
| FEVAROL (125mg+2,5mg+1mg)/5mL Sirop F/100mL | PARACETAMOL + PHENYLEPHRINE HYDROCHLORIDE + CHLORPHENAMINE MALEATE | BEKRA PHARMA | Inde | 852.74 | AMM_2018_4343 | 2023-10-09 |
| FEVAROL 500mg+5mg+2mg+30mg Comprimé B/50x4 | PARACETAMOL + PHENYLEPHRINE HYDROCHLORIDE + CHLORPHENAMINE MALEATE + CAFEINE | BEKRA PHARMA | Inde | 7543.51 | AMM_2018_4337 | 2023-10-09 |
| IBUTIN 300mg Comprimé pélliculé à libération prolongée B/20 | TRIMEBUTINE | GALENICA S.A. | Maroc | 2755.02 | AMM_2016_1223 | 2023-10-09 |
| NARISOL 0,005mg/mL Solution pour pulvérisation nasale Fl/10 mL | XYLOMETAZOLINE | BEKRA PHARMA | Inde | 688.75 | AMM_2018_4333 | 2023-10-09 |
| NARISOL 0,010mg/mL Solution pour pulvérisation nasale Fl/10 mL | XYLOMETAZOLINE | BEKRA PHARMA | Inde | 787.15 | AMM_2018_4338 | 2023-10-09 |
| NEUROGIL-75 75mg Comprimé B/20 | PREGABALINE | BEKRA PHARMA | Inde | 4263.72 | AMM_2018_4314 | 2023-10-09 |